PATENT CLAIM ANALYSIS

Application Number: 15986992
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "009100"]

Abstract:
S1P receptor modulators are administered following a dosage regimen providing a positive benefit-risk profile.

Claim (Index 31):
The method according to  claim 29 , wherein treating comprises delaying the accumulation of physical disability induced by multiple sclerosis.

Metadata:
- Claim Count in Document: 101.0
- Percentile: 93.0
- Lexical Diversity: 1.07143
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12655049', '14973105', '15418572', '13985342', '13149468']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.692053323878497
- 35 USC 102 Novelty (BERT): 0.5298757980280929
- Combined Prediction Score: 0.6758355712934567
- Mean Citation Score: 219.731472
- Max Citation Score: 239.65294
- Similarity Product: 116.84405991418778

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test